69,932 research outputs found

    Risk Assessment for Developmental Toxicity: Airborne Occupational Exposure to Ethanol and Iodine

    Get PDF
    Dean Mattison explains hazard identification, hazard characterization and exposure characterization as furnishing a foundation for Risk assessment generally. He then illustrates their application in assessing the fetal Risk posed by two common substances. Ultimately, he argues that only after Risks have been so examined can women of child bearing age (or anyone) decide what if any measures are appropriate to avoid them

    Daganatos sejtek rezisztenciáját gátló vegyületek fejlesztése = Development of compounds targeting multidrug resistant cancer

    Get PDF
    A korszerű daganatellenes terápia jelentős sikerei ellenére a kemoterápiával szemben fellépő rezisztencia (multidrog rezisztencia, MDR) továbbra is megoldásra váró klinikai kihívás. Számos rosszindulatú megbetegedés, valamint az áttétet adó daganatok hatékony kezelése a terápia során rendszerint kialakuló MDR hatás miatt a mai napig nem megoldott. A rezisztens fenotípus gyakran társul az ABC-transzporterek családjába tartozó fehérjék emelkedett expressziójával. E család legismertebb képviselője a Pgp (ABCB1) membránfehérje, mely az ATP energiáját felhasználva megakadályozza a citosztatikus vegyületek sejten belüli felhalmozódását. A farmakogenomikai megközelítés révén lehetővé válik a személyre szabott gyógyítás, a daganatos megbetegedések molekuláris profiljához igazított kemoterápiás kezelés. A kutatás fő célja az volt, hogy a korábban kidolgozott farmakogenomikai módszer segítségével olyan ?MDR-inverz? vegyületeket fedezzünk fel, melyek szelektíven elpusztítják az egyébként multidrog rezisztens sejteket. Fontosabb eredményeink a következő pontokban összegezhetők: (i) módszerünk számos további MDR-inverz vegyületet azonosított; (ii) a szerkezetek analízise lehetővé tette QSAR modellek felállítását; (iii) javaslatot tettünk a vegyületek hatásmechanizmusára. Távlati tervünk, hogy a megismert MDR-inverz vegyületekből kiindulva originális gyógyszerkutatást folytassunk a rákos sejteket szelektíven pusztító molekulák preklinikai fejlesztése céljából. | Despite considerable advances in drug discovery, resistance to chemotherapy confounds the effective treatment of cancer patients. Cancer cells can become resistant to a single drug or they may acquire broad cross-resistance to mechanistically and structurally unrelated drugs (multidrug resistance (MDR)). ATP-Binding Cassette (ABC) proteins comprise the largest protein family, many members of which are of immediate medical importance and relevant to human health. The application of pharmacogenetics has the potential to improve the management of patients, particularly by providing the molecular basis for choosing among the increasing number of chemotherapeutic agents available for the treatment. The major aim of this project was to apply a pharmacogenomic approach to discover ?MDR-inverse? compounds that selectively kill multidrug resistant cancer cells. The results can be summarized as follows: (i) we identified a series of MDR-inverse compounds; (ii) we delineated structural features associated with their cytotoxic activity; (iii) we proposed a mechanism of action for the toxicity of newly identified MDR1-inverse compounds. Our future aim is to establish the framework for the preclinical development of the most promising MDR-inverse molecules, setting the stage for a fresh therapeutic approach that may eventually translate into improved patient care

    Superior removal of arsenic from water with zirconium metal-organic framework UiO-66

    Get PDF
    10.1038/srep16613Scientific Reports51661

    Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

    Get PDF
    Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety 'Mode of Action' framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology

    An evaluation of metal removal during wastewater treatment: The potential to achieve more stringent final effluent standards

    Get PDF
    This is the author's accepted manuscript. The final published article is available from the link below. Copyright @ 2011 Taylor & Francis.Metals are of particular importance in relation to water quality, and concern regarding the impact of these contaminants on biodiversity is being encapsulated within the latest water-related legislation such as the Water Framework Directive in Europe and criteria revisions to the Clean Water Act in the United States. This review undertakes an evaluation of the potential of 2-stage wastewater treatment consisting of primary sedimentation and biological treatment in the form of activated sludge processes, to meet more stringent discharge consents that are likely to be introduced as a consequence. The legislation, sources of metals, and mechanisms responsible for their removal are discussed, to elucidate possible pathways by which the performance of conventional processes may be optimized or enhanced. Improvements in effluent quality, achievable by reducing concentrations of suspended solids or biochemical oxygen demand, may also reduce metal concentrations although meeting possible requirements for the removal of copper my be challenging
    corecore